HOME >> BIOLOGY >> NEWS
Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease

Blacksburg, Va., June 10, 2004 Virginia Bioinformatics Researcher Brett Tyler and his colleagues are one step closer to finding a cure for a disease affecting California oak trees that is now showing up in nurseries in a dozen states, including Virginia, and threatening woody ornamentals and East Coast forests.

Tyler and his colleagues have successfully mapped the genome of the devastating pathogens Phytophtora sojae and Phytophtora ramorum. P. ramorum, also known as sudden oak death, is a serious fungal pathogen that has attacked and killed tens of thousands of California and Oregon oak trees. P. sojae, the sister pathogen to P. ramorum, causes serious damage to soybean crops and cost growers $1 billion worldwide last year.

The sequences of P. sojae will act as a "Rosetta Stone" to help researchers better understand P. ramorum's genome makeup and uncover valuable information to help cure and prevent sudden oak death disease. In addition, the sequencing of the P. ramorum genome represents the fastest tracking time between the identification of a complex pathogen (in 2000) and the completion of its genome (in 2004).

Tyler, along with representatives from the Department of Energy Joint Genome Institute (JGI at www.jgi.doe.gov), United States Department of Agriculture (USDA), USDA Forest Service, the National Science Foundation (NSF) and others will present the scientific findings to the media on June 10, 2004 at the Joint Genome Institute in Walnut Creek, California.

Sudden oak death disease has the potential to affect forests in the Appalachian highlands in Virginia and other areas on the East Coast. The disease kills the oak tree, but usually the carrier shrubs survive. Sudden oak death has affected California redwood seedlings and sprouts, but not the trunks. However, it poses a large threat to Virginia oak trees and other Eastern Seaboard plant species that have proven highly susceptible to the pathogen in greenhouse tests. Tyler i
'"/>

Contact: Blanche O'Neill
oneill@vbi.vt.edu
540-231-1976
Virginia Tech
10-Jun-2004


Page: 1 2

Related biology news :

1. Two Virginia Tech energy-related inventions win R&D 100 awards
2. Virginia Tech researchers to release findings on Smith River Project
3. Virginia Tech professor honored with DeLaval Award
4. Virginia Techs smelly corpse plant due to bloom Aug. 4
5. Virginia Center for Coal and Energy Research helps implement global climate change initiative
6. Cell cycle research earns biologist Virginias top scientist award
7. Virginia Tech-led group receives third five-year international biodiversity grant
8. Virginia Tech researcher receives $1.8 million to study Arabidopsis genome
9. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
10. Virginia Bioinformatics Institute central to Regional Center of Excellence
11. NIH awards $1 million to Virginia Bioinformatics Institute to study biochemical network modeling

Post Your Comments:
(Date:12/17/2014)... Dec. 16, 2014  Automation is fundamentally transforming ... evident than at international borders. Over the past ... have allowed veteran travelers to self process through ... (APC) Kiosks at an increasing number of airports, ... According to Maxine Most , ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 This ... Global Quartz Tubing industry. For an overview analysis, ... classification, application, industry chain structure, industry overview, policy ... quartz tubing industry has witnessed rapid development ... number of acquisitions. This report mentions quartz tubing ...
(Date:12/17/2014)... Diego, CA (PRWEB) December 17, 2014 ... and activation agency and member of the Huntsworth Health ... Gonzales to its executive team. In her role, Gonzales ... , “We are incredibly honored to welcome a ... Agency Chief and CEO, Gaëtan Fraikin. “She is a ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a primary commercial focus on ... has been granted a Type C meeting with the ... meeting will be held in February 2015.  During this ...
(Date:12/15/2014)... 15, 2014 METTLER TOLEDO is ... tool, ParticleView V19 with PVM technology , ... particle vision and measurement tool continuously captures high-resolution ... ParticleView V19 then automatically prepares a report pairing ... size and concentration changes. This compelling blend of ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
Cached News: